Skip to main content

Disclaimer

In the Downloads section, the ‘Prior Submission’ file reflects the most recent measure submission to the former CBE. This file is provided for transparency. For any questions or clarification, please contact the designated measure steward.

Anti-Platelet Medication at Discharge

CBE ID
0116
Endorsement Status
E&M Committee Rationale/Justification

Endorsed with reserve status ended. Steward no longer seeking endorsement. 

1.1 Measure Structure
Previous Endorsement Cycle
Is Under Review
No
1.6 Measure Description

Percent of patients aged 18 years and older undergoing isolated CABG who were discharged on anti-platelet medication

    Measure Specs
      General Information
      1.7 Measure Type
      1.3 Electronic Clinical Quality Measure (eCQM)
      No
      1.8 Level of Analysis
      1.9 Care Setting
      1.20 Types of Data Sources
      1.14 Numerator

      Number of patients undergoing isolated CABG who were discharged on anti-platelet medication

      1.15 Denominator

      All patients undergoing isolated CABG

      Exclusions

      Cases are removed from the denominator if there was an in-hospital mortality or if discharge aspirin was contraindicated.

      Most Recent Endorsement Activity
      Endorsed with Reserve Status Surgery Endorsement Maintenance Project 2014
      Initial Endorsement
      Last Updated
      Removal Date
      Steward Organization
      The Society of Thoracic Surgeons
      Steward POC email
                  Public Comments